Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Rapid Micro Biosystems, Inc. (RPID)

0.7028 -0.0331 (-4.50%)
At close: November 2 at 4:00:00 PM EST
0.7100 +0.0072 (+1.02%)
Pre-Market: 7:47:16 AM EST
Trade RPID on Coinbase
Chart Range Bar
Loading chart for RPID
  • Previous Close 0.7359
  • Open 0.7600
  • Bid 0.8628 x 300
  • Ask 1.8600 x 100
  • Day's Range 0.7000 - 0.7899
  • 52 Week Range 0.7000 - 4.9400
  • Volume 77,262
  • Avg. Volume 250,278
  • Market Cap (intraday) 35.252M
  • Beta (5Y Monthly) 1.48
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1100
  • Earnings Date (est.) Nov 6, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 5.75
  • Motley Fool Rating Bearish

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

www.rapidmicrobio.com

171

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RPID
75.77%
S&P 500 (^GSPC)
10.17%

1-Year Return

RPID
76.49%
S&P 500 (^GSPC)
10.25%

3-Year Return

RPID
30.76%
S&P 500 (^GSPC)
74.66%

5-Year Return

RPID
96.71%
S&P 500 (^GSPC)
62.86%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 8.05M
Earnings -12.92M
Profit Margin -160.45%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
-5M
0
5M
10M
-160.0%
-140.0%
-120.0%

Analyst Insights

View More

Analyst Price Targets

3.00
5.75 Average
0.7028 Current
8.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/29/2026
Analyst Roth Capital
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 3

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -145.55%

  • Return on Assets (ttm)

    -46.40%

  • Return on Equity (ttm)

    -141.65%

  • Revenue (ttm)

    35.18M

  • Net Income Avi to Common (ttm)

    -51.2M

  • Diluted EPS (ttm)

    -1.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.5M

  • Total Debt/Equity (mrq)

    132.28%

  • Levered Free Cash Flow (ttm)

    -21.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: